Teclistamab,Daratumumab,Pomalidomide,Lenalidomide,Bortezomib,Nirogacestat
Genmab,Janssen,springworks therapeutics
['majestec,(-majestec-1),(-majestec1),(-majestec 1),(-majestec-3),(-majestec3),(-majestec 3),(-majestec-i),(-majestec i),(-majesteci)', 'nirogacestat', 'majestec-2', 'teclistamab', 'mmsm', 'multiple myeloma']
#eha2023 teclistamab + nirogacestat (gamma-secretase inhibitor) in r/r multiple myeloma #mmsm jeffrey matous presents the ph1b majestec-2 trial (1/2) 
The Lancet Haematology is a world-leading #haematology journal publishing peer-reviewed research and reviews, opinion, and news. #hematology